EGM
FULC icon

Engineers Gate Manager’s Fulcrum Therapeutics FULC Stock Holding History

Engineers Gate Manager’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$967K Buy
+126,109
New +$1.17M 0.01% 1070
2025
Q2 		– Sell
-12,519
Closed -$36.1K – 2282
2025
Q1 		$36.1K Buy
+12,519
New +$46K ﹤0.01% 2058
2024
Q4 		– Sell
-25,234
Closed -$90.1K – 2346
2024
Q3 		$90.1K Buy
25,234
+5,374
+27% +$39.9K ﹤0.01% 1928
2024
Q2 		$123K Buy
+19,860
New +$150K ﹤0.01% 1721
2023
Q2 		– Sell
-29,822
Closed -$85K – 1833
2023
Q1 		$85K Buy
+29,822
New +$267K ﹤0.01% 1523
2022
Q3 		– Sell
-21,356
Closed -$105K – 1779
2022
Q2 		$105K Buy
+21,356
New +$209K ﹤0.01% 1729
2021
Q3 		– Sell
-11,773
Closed -$123K – 1754
2021
Q2 		$123K Sell
11,773
-5,371
-31% -$54.3K 0.01% 1475
2021
Q1 		$202K Sell
17,144
-2,667
-13% -$33K 0.01% 1593
2020
Q4 		$232K Sell
19,811
-294
-1% -$3.32K 0.01% 1440
2020
Q3 		$159K Buy
+20,105
New +$242K 0.01% 1476

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Engineers Gate Manager's FULC Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Fulcrum Therapeutics (FULC) in Q1 2026: 126,109 shares worth $967K. The stake represents 0.01% of the portfolio and ranks #1070 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in FULC as recently as Q1 2025.

Engineers Gate Manager first reported a position in FULC in Q3 2020 and has held it in 10 quarters since. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Engineers Gate Manager held 126,109 shares of Fulcrum Therapeutics worth $967K as of Q1 2026.
  • Fulcrum Therapeutics was a new Engineers Gate Manager position in Q1 2026.
  • Fulcrum Therapeutics made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1070 holding.
  • Engineers Gate Manager first reported a position in Fulcrum Therapeutics in Q3 2020 and has held it in 10 quarters since.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.